Abstract:This review focuses on structural characteristics, functional properties, and computational approaches driving the design and optimisation of synthetic nanobodies. We discuss recent advancements in computational methods for nanobody modelling, epitope prediction, and affinity maturation, shedding light on their intricate antigen‐binding mechanisms and conformational dynamics. It underscores their advantages over conventional antibodies from a biosynthesis perspective in diagnostics, therapeutics, and biosensing. Nanobodies, the smallest functional antibody fragment derived from camelid heavy‐chain‐only antibodies, have emerged as powerful tools for diverse biomedical applications. In this comprehensive review, we discuss the structural characteristics, functional properties, and computational approaches driving the design and optimisation of synthetic nanobodies. We explore their unique antigen‐binding domains, highlighting the critical role of complementarity‐determining regions in target recognition and specificity. This review further underscores the advantages of nanobodies over conventional antibodies from a biosynthesis perspective, including their small size, stability, and solubility, which make them ideal candidates for economical antigen capture in diagnostics, therapeutics, and biosensing. We discuss the recent advancements in computational methods for nanobody modelling, epitope prediction, and affinity maturation, shedding light on their intricate antigen‐binding mechanisms and conformational dynamics. Finally, we examine a direct example of how computational design strategies were implemented for improving a nanobody‐based immunosensor, known as a Quenchbody. Through combining experimental findings and computational insights, this review elucidates the transformative impact of nanobodies in biotechnology and biomedical research, offering a roadmap for future advancements and applications in healthcare and diagnostics.

Epitope Identification of an mGlu5 Receptor Nanobody Using Physics-Based Molecular Modeling and Deep Learning Techniques

Characterization of a nanobody-epitope tag interaction and its application for receptor engineering

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Nanobody-based Sensors Reveal a High Proportion of Mglu Heterodimers in the Brain

AI driven approaches in Nanobody Epitope Prediction: Are We There Yet?

Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking

Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist

The emerging role of biosensor-based epitope binning and mapping in antibody-based drug discovery

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Novel Scaffold Identification of mGlu1 Receptor Negative Allosteric Modulators Using a Hierarchical Virtual Screening Approach

Pharmacological characterisation of allosteric modulators at human mGlu5

Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations

Epitope Mapping and Binding Assessment by Solid-State NMR Provide a Way for the Development of Biologics under the Quality by Design Paradigm

Dissecting Conformational Rearrangements and Allosteric Modulation in Metabotropic Glutamate Receptor Activation

Integrated in Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5

Nanobody engineering: computational modelling and design for biomedical and therapeutic applications

Recognition Mechanisms between a Nanobody and Disordered Epitopes of the Human Prion Protein: An Integrative Molecular Dynamics Study

Computational Design of an Epitope-Specific Keap1 Binding Antibody Using Hotspot Residues Grafting and CDR Loop Swapping